Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 6 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 7 days agoIt aims to develop or acquire lower-risk, less splashy drugs it knows it can market. Underscoring...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 6 days agoThe body was created in 2021 to review prescription drugs and evaluate their affordability for...
Amgen Inc. (NASDAQ:AMGN) Stock Position Decreased by PSI Advisors LLC
ETF DAILY NEWS· 2 days agoPSI Advisors LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 31.8% in the fourth quarter, according to the company in its most recent filing with the Securities ...
Sumitomo Mitsui DS Asset Management Company Ltd Has $4.59 Million Stock Position in Biogen Inc....
ETF DAILY NEWS· 23 hours agoSumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.4% during the 4th quarter, according to the company in its most ...
Greenleaf Trust Increases Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 22 hours agoGreenleaf Trust increased its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 20.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission ...
Biogen (BIIB) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 2 days agoBiogen (NASDAQ:BIIB – Get Free Report) will be announcing its earnings results before the market opens on Wednesday, April 24th. Analysts expect the company to announce earnings of $3.48 per ...
Desjardins Global Asset Management Inc. Has $115,000 Holdings in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoDesjardins Global Asset Management Inc. cut its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 86.0% in the 4th quarter, according to its most recent Form 13F filing with the ...
Biogen (NASDAQ:BIIB) Price Target Cut to $214.00
ETF DAILY NEWS· 5 days agoBiogen (NASDAQ:BIIB – Get Free Report) had its price target reduced by equities research analysts at UBS Group from $250.00 to $214.00 in a research note issued on Wednesday, Benzinga reports ...
Federated Hermes Inc. Decreases Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 2 days agoFederated Hermes Inc. lessened its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...